Capricor Therapeutics, Inc. 8-K Dec. 22, 2017 4:04 PM
FORM 8-K | Current report CAPRICOR THERAPEUTICS, INC. (Form: 8-K, Received: 12/22/2017 16:05:23) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.
Name: Leland Gershell
Continent: North America
Country: USA
Company: Capricor Therapeutics, Inc.
Branch: Biotech
Position: CFO
Reason: Resigned
Announcement Date: December 19, 2017, 11:00pm
Resignation Date: December 19, 2017, 11:00pm
Source 1: https://seekingalpha.com/filing/3795249